Core Viewpoint - Catheter Precision, Inc. is actively participating in the 18th Western Atrial Fibrillation Symposium to promote its LockeT product line, which is designed to enhance atrial fibrillation procedures and improve patient outcomes [1][3]. Company Overview - Catheter Precision is a U.S.-based medical device company focused on developing innovative solutions for cardiac arrhythmias, particularly in the electrophysiology market [5]. - The company aims to collaborate with physicians to continuously advance its product offerings [5]. Product Information - The LockeT is a suture retention device that assists in hemostasis after vascular catheter access and is classified as a Class 1 device registered with the FDA [4]. - The product is positioned as an adjunctive tool for atrial fibrillation procedures, with the potential to benefit recovery room staff, hospitals, and patients [3]. Industry Event - The Western Atrial Fibrillation Symposium is an internationally recognized event aimed at improving atrial fibrillation outcomes, featuring over 80 leading experts discussing advancements in diagnosis and treatment [2].
Catheter Precision to Attend and Participate in the Western Atrial Fibrillation Symposium